Immune System Diseases Completed Phase 2 Trials for Arsenic trioxide (DB01169)

Also known as: Immune System Disease

IndicationStatusPhase
DBCOND0029769 (Immune System Diseases)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02966301Treatment of Chronic Graft Versus Host Disease With Arsenic TrioxideTreatment